XNCR Latest Press Releases

-- July 17, 2026 --

Xencor Announces Proffered Paper Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinoma Business Wire 9:11 AM

-- July 6, 2026 --

A Clinical-Stage Cancer Company Is Putting AI to Work at the Bench, Designing Its Next Generation of Tumor-Targeting Drugs PRNewswire 11:20 AM

-- May 18, 2026 --

The Biology Came First. Business Wire 8:34 AM

-- May 6, 2026 --

Xencor Reports First Quarter 2026 Financial Results Business Wire 4:01 PM

-- May 4, 2026 --

Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW Business Wire 8:01 AM

-- March 4, 2026 --

Xencor Announces Change to Ultomiris Royalty Revenue Forecast Business Wire 4:01 PM

-- February 25, 2026 --

Xencor Reports Fourth Quarter and Full Year 2025 Financial Results Business Wire 4:04 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software